Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Structural genomics in the biotechnology sector

Nature Structural Biology volume 7, pages 946–949 (2000)Cite this article

Abstract

Commercial efforts in structural genomics focus on providing to pharmaceutical customers information that relates to the suitability of specific proteins as drug targets and the informed selection and refinement of lead compounds generated by high-throughput screening and rational approaches. These efforts follow a variety of business models and are impacted by activities in the public domain, recent technological advances, and the changing intellectual property landscape.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Potential impact of structural genomics on drug discovery.

Similar content being viewed by others

References

  1. Boggon, T.J., Shan, W.S., Santagata, S., Myers, S.C. & Shapiro, L. Science, 286, 2119–2125 (1999).

    Article  CAS  Google Scholar 

  2. Shapiro, L. & Scherer, P.W. Curr. Biol. 8, 335–338 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Structural GenomiX Inc., 10505 Roselle Street, San Diego, 92121, California, USA

    Sarah Dry, Sean McCarthy & Tim Harris

Authors
  1. Sarah Dry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tim Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dry, S., McCarthy, S. & Harris, T. Structural genomics in the biotechnology sector. Nat Struct Mol Biol 7 (Suppl 11), 946–949 (2000). https://doi.org/10.1038/80718

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/80718

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing